Abstract: Today, making decisions in multi-parameter contexts requires long computational times and increasingly powerful computers. In addition, we are often interested not only in the final decision ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
Abstract: Glaucoma, an irreversible neurodegenerative disorder, can lead to vision loss and blindness. Visual field (VF) tests are crucial for quantifying functional damage in glaucoma, but the tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results